May 14, 2026 04:05PM
Apr 24, 2026 04:05PM
Apr 6, 2026 05:54AM
Apr 3, 2026 04:10PM
Apr 3, 2026 04:05PM
Mar 30, 2026 04:06PM
Mar 30, 2026 04:05PM AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program
Mar 25, 2026 08:00AM
Mar 25, 2026 08:00AM
Mar 9, 2026 04:05PM
Mar 9, 2026 04:05PM
Mar 5, 2026 04:05PM
Jan 21, 2026 04:05PM
Jan 21, 2026 04:05PM AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
Dec 19, 2025 06:00PM
Dec 15, 2025 04:05PM
Dec 15, 2025 04:05PM
Nov 20, 2025 08:30AM
Nov 14, 2025 08:30AM
Nov 14, 2025 08:30AM
May 23, 2025 04:05PM AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
May 19, 2025 04:05PM
May 14, 2025 04:05PM
Apr 25, 2025 04:05PM
Apr 25, 2025 04:05PM
Apr 21, 2025 04:10PM
Apr 21, 2025 04:05PM
Apr 21, 2025 04:05PM AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer
Mar 27, 2025 04:05PM
Mar 27, 2025 04:05PM
Mar 24, 2025 04:05PM
Mar 4, 2025 08:00AM
Feb 24, 2025 02:01PM
Feb 24, 2025 02:00PM
Feb 7, 2025 04:05PM AEON Biopharma (AEON) Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Feb 7, 2025 04:05PM
Jan 7, 2025 09:37AM
Jan 6, 2025 09:03AM
Jan 6, 2025 09:00AM
Jan 3, 2025 08:02PM
Nov 13, 2024 04:05PM
Oct 1, 2024 07:07AM H.C. Wainwright Reiterates Buy Rating on AEON Biopharma, Inc (AEON)
Sep 30, 2024 08:03AM
Sep 30, 2024 08:00AM
Aug 19, 2024 04:05PM
Aug 14, 2024 06:43AM
Aug 12, 2024 04:05PM
Jul 10, 2024 08:34AM
Jul 9, 2024 08:00AM AEON Biopharma Announces Strategic Reprioritization to Pursue a Biosimilar Pathway for ABP-450
May 29, 2024 08:01AM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All